Právní předpis byl sestaven k datu 09.02.2026.
Zobrazené znění právního předpisu je účinné od 17.12.2016.
Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2017
390/2016 Sb.
390
XXXXXXX
Xxxxxxxxxxxx xxxxxxxxxxxxx
xx xxx 28. xxxxxxxxx 2016
o xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx x mimořádná xxxxxxxx xxx xxx 2017
Xxxxxxxxxxxx xxxxxxxxxxxxx podle §80 odst. 1 xxxx. e) zákona x. 258/2000 Sb., x xxxxxxx xxxxxxxxx xxxxxx x x xxxxx xxxxxxxxx souvisejících xxxxxx, xx znění xxxxxxxxxx xxxxxxxx, xxxxxxx xx xxxxxxx xxxxxxxxxx Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx a xxxxxxxxx xxxxxxxx xxx xxx 2017:
1. Xxxxxxxxx xxxxxxx xxxxxxxxxx látek xxx xxxxxxxxxx xxxxxxxx
1x) xxxxxxxxxxx xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx forma), virové xxxxxxxxxx B, nákazám xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (DTaPHibVHBIPV):
Diphtheriae xxxxxxxxxx1 xx xxxx xxx 30 mezinárodních xxxxxxxx (IU)
Tetani anatoxinum1 xx xxxx xxx 40 mezinárodních xxxxxxxx (XX)
Xxxxxxxx Xxxxxxxxxx pertussis:
Pertussis xxxxxxxxxx1 25 xxxxxxxxxx
Xxxxxxxxxxxxxxxx xxxxxxxxxxxx1 25 xxxxxxxxxx
Xxxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx tegiminis xxxxxxxxxxx B2,3 10 xxxxxxxxxx
Xxxxx poliomyelitis (inaktivovaný)
typus 1 (kmen Xxxxxxx)4 40 X jednotek xxxxxxxx
xxxxx 2 (xxxx XXX-1)4 8 D xxxxxxxx xxxxxxxx
xxxxx 3 (xxxx Saukett)4 32 X xxxxxxxx antigenu
Haemophilus xxxxxxxxxx xxxxx x xxxxxxxxxxxxxxx 10 xxxxxxxxxx
(xxxxxxxxxxxxxxxxxxx xxxxxxxx)3
xxxxxxxxx cum tetani xxxxxxxxxx xxxx nosným xxxxxxxxx přibližně 25 xxxxxxxxxx
XXXX
1xx) kombinovaná xxxxxxxx xxxxx xxxxx záškrtu, xxxxxxxx kašli (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx hepatitidě X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (DTaPHibVHBIPV)
Diphtheriae xxxxxxxxxx xx méně xxx 20 xxxxxxxxxxxxx xxxxxxxx (XX)2
Xxxxxx xxxxxxxxxx xx xxxx xxx 40 xxxxxxxxxxxxx jednotek (XX)2
Xxxxxxxx Xxxxxxxxxx pertussis
Pertussis anatoxinum 25 mikrogramů
Haemagglutinum xxxxxxxxxxxx 25 xxxxxxxxxx
Xxxxx Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)3
xxxxx 1 (Xxxxxxx) 40 X jednotek xxxxxxxx4
xxxxx 2 (XXX-1) 8 X xxxxxxxx xxxxxxxx4
xxxxx 3 (Saukett) 32 D xxxxxxxx xxxxxxxx4
Xxxxxxxxx tegiminis xxxxxxxxxx X5 10 xxxxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx typu b xxxxxxxxxxxxxxx 12 xxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)
xxxxxxxxx cum tetani xxxxxxxxxx 22-36 xxxxxxxxxx
1x) xxxxxxxx xxxxx proti xxxxxxx, dávivému xxxxx (xxxxxxxxxx forma), xxxxxx (XXxX):
Xxxxxxxxxxx xxxxxxxxxx ³ 30 mezinárodních xxxxxxxx
Xxxxxx xxxxxxxxxx ³ 40 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx (XX) 25 mikrogramů
Pertussis xxxxxxxxxxxxxxx xxxxxxxxxxxx (FHA) 25 mikrogramů
Pertactinum (69xX) 8 xxxxxxxxxx
XXXX
1xx) Očkovací xxxxx xxxxx záškrtu, xxxxxx x xxxxxxxx xxxxx (xxxxxxxxxx)
|
1 xxxxx (0,5 xx) xxxxxxxx: Xxxxxxxxxxx xxxxxxxxxx |
Xxxxxxxxx 2 XX* (2 Xx) |
|
Xxxxxx xxxxxxxxxx |
Xxxxxxxxx 20 IU* (5 Xx) |
|
Xxxxxxxxx xxxxxxxx |
|
|
Xxxxxxxxx xxxxxxxxxx |
2,5 mikrogramů |
|
Haemagglutinum xxxxxxxxxxxx |
5 xxxxxxxxxx |
|
Xxxxxxxxxxx |
3 mikrogramy |
|
Fimbriae, xxxx 2 xx 3 |
5 xxxxxxxxxx |
|
Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx |
1,5 mg (0,33 xx xxxxxxx) |
XXXX
1xx) Xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxx x xxxxxxxx xxxxx (xxxxxxxxxx xxxxxxxxxx) xx sníženým xxxxxxx xxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx než 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Xx)
Xxxxxx anatoxinum1 xx xxxx než 20 xxxxxxxxxxxxx xxxxxxxx (XX) (5 Lf)
Bordetellae xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 8 mikrogramů
Pertussis xxxxxxxxxxxxxx xxxxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxx proteinum1 2,5 xxxxxxxxxx
1 xxxxxxxxxxx xx hydratovaný hydroxid xxxxxxx (AI(OH)3) 0,3 xxxxxxxxx XX3+
x xxxxxxxxxxx xxxxxxx (XXX04) 0,2 xxxxxxxxx XX3+
1x) očkovací xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (acelulární xxxxx), xxxxxx, xxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxx x (XXxXXxx):
|
Xxxxxxxxxxx anatoxinum |
min. 30 xxxxxxxxxxxxx jednotek |
|
Tetani xxxxxxxxxx |
xxx. 40 mezinárodních xxxxxxxx |
|
Xxxxxxxxx xxxxxxxxxx (XX) |
25 xxxxxxxxxx |
|
Xxxxxxxxx haemaglutininum filamentosum |
(FHA) 25 xxxxxxxxxx |
|
Xxxxxxxxxxx (69xX) |
8 xxxxxxxxxx |
|
Xxxxxxxxxxx xxxxxxxxxx B |
10 xxxxxxxxxx |
|
xxx anatoxino tetanico |
20-40 xxxxxxxxxx |
1x) xxxxxxxx látka xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x:
1 xxxxx lyofilizované xxxxxxx xxxxxxxx: Polysaccharidum Xxx purificatum (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (přibližně 25 xxxxxxxxxx).
1x) xxxxxxxx látka xxxxx xxxxxx:
Xxxxxx xxxxxxxxxx … xxx. 40 xxxxxxxxxxxxx jednotek
1f) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X xx 16 xxx a xxxx:
|
Xxxxxxxxx xxxxxxxxx hepatitidis X |
20 mikrogramů |
1g) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx B x xxxxxx xxxxxxx:
|
Xxxxxxxxx tegiminis xxxxxxxxxxx B |
10 xxxxxxxxxx |
1x) xxxxxxxx xxxxx proti xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx (Xxxxxxx) xxx. 103,0 xxxxxxxx dávka xxx xxxxxxxx kulturu50 Xxxxxxxxxxx xxxxx xxxxxxxxxx (RIT 4385) xxx. 103,7 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx50 Rubeolae xxxxx xxxxxxxxxx (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx dávka xxx xxxxxxxx kulturu50
1ch) xxxxxxxx xxxxx proti xxxxxx xxxxxxxx xxxxx x xxxxxxxxxxxx formě:
Virus xxxxxxxxxxxxx xxxxxxxxxxx typus 1 (Xxxxxxx) … 40 xxxxxxxxxxx D xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2 (MEF-1) … 8 antigenních X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3 (Xxxxxxx) … 32 xxxxxxxxxxx X jednotek*
* xxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxx xxxxxx imunochemické xxxxxx.
1x) xxxxxxxx látka xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx x xxxxxxxxxxxxxxx xxxxxxx:
Xxxxxxxxxxxxxxx Xxxxxxxxxxxx pneumoniae xxxxx:
1, 2, 3, 4, 5, 6B, 7X, 8, 9X, 9X, 10A, 11X, 12X, 14, 15B, 17X,
18X, 19X, 19F, 20, 22F, 23F, 33X … 25 xxxxxxxxxx x každého xxxxxxxx
1x) xxxxxxxx xxxxx xxxxxxxxxxx xxxxx pneumokokovým xxxxxxxx:
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 1
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 3
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 4
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 5
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 6X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9X
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 14
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 18X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X
1x) xxxxxxxx xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, dětské xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
|
Xxxxxxxxxxx anatoxinum |
ne xxxx xxx 2 xxxxxxxxxxx xxxxxxxx |
|
Xxxxxx xxxxxxxxxx |
xx méně xxx 20 mezinárodních xxxxxxxx |
|
Xxxxxxxxx xxxxxxxx: |
|
|
Xxxxxxxxx xxxxxxxxxx |
8 xxxxxxxxxx |
|
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx |
8 xxxxxxxxxx |
|
Xxxxxxxxx |
2,5 xxxxxxxxxx |
|
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx: |
|
|
xxxxx 1 (xxxx Xxxxxxx) |
40 X jednotek xxxxxxxx |
|
xxxxx 2 (xxxx XXX-1) |
8 X xxxxxxxx xxxxxxxx |
|
xxxxx 3 (xxxx Xxxxxxx) |
2 X jednotek xxxxxxxx |
XXXX
1x) očkovací xxxxx xxxxx záškrtu, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx forma):
|
Difterický xxxxxx |
xxxx xxxx xxxxx 2 mezinárodní jednotky (2 Lf) |
|
Tetanický toxoid |
více xxxx xxxxx 20 xxxxxxxxxxxxx xxxxxxxx (5 Xx) |
|
Xxxxxxxxx antigeny: |
|
|
Xxxxxxxxx xxxxxx |
2,5 xxxxxxxxxx |
|
&xxxx;&xxxx; Xxxxxxxxxxxx xxxxxxxxxxxx |
5 xxxxxxxxxx |
|
&xxxx;&xxxx; Xxxxxxx xxxx 2+3 |
5 mikrogramů |
|
Xxxxxxxxx |
3 xxxxxxxxxx |
|
Xxxxx poliomyelitis xxxx 1 (xxxxxxxxxxxx) |
40 xxxxxxxxxxx X xxxxxxxx |
|
Xxxxx xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx) |
8 xxxxxxxxxxx X xxxxxxxx |
|
Xxxxx poliomyelitis xxxx 3 (xxxxxxxxxxxx) |
32 antigenních X xxxxxxxx |
1x) xxxxxxxx xxxxx xxxxx xxxxxxxxxxx (XXX vakcína)
1n) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X xxx xxxxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxx tegiminis xxxxxxxxxxx B biosyntheticum 20 xxxxxxxxxx; xxxxxxxx XX04X xxxxxxxxxx 3-O-deacyl-4-monofosforyl-lipid X (XXX) 50 xxxxxxxxxx v 1 xxxxx
2. Antigenní xxxxxxx xxxxxxxxxx látek pro xxxxxxxx xxxxxxxx
2x) očkovací xxxxx proti xxxxxx xxxxxxxxxx X xx xxxxxxx pro xxxxxxx:
|
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X |
20 xxxxxxxxxx |
2x) xxxxxxxx látka xxxxx vzteklině
2c) očkovací xxxxx proti xxxxxx xxxxxxxxxx A xx xxxxxxx pro xxxxxxx:
Xxxxxxxxx X xxxxx inactivatum
3. Xxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxx xxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X ve formuli xxx xxxxxxx:
Xxxxxxxxx X xxxxx inactivatum
3b) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X ve xxxxxxx xxx xxxx:
Xxxxx xxxxxxxxx X inactivatum
V xxxx 2017 x xxxxxxx na plánovanou xxxxxxxxxx xxxxxxxx č. 537/2006 Sb., x očkování xxxxx xxxxxxxxx nemocem, xx xxxxx xxxxxxxxxx xxxxxxxx, xxxxx xxxxxxxx xxxxxxxxx xxxxxx xxxxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxxxx xxxxxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xx Sbírce xxxxxx.
Xxxxxxx:
XXXx. Xxxxxxx, MBA, x. x.
Informace
Právní xxxxxxx x. 390/2016 Xx. nabyl xxxxxxxxx dnem 17.12.2016.
Xx xxx xxxxxxxx xxxxxx xxxxxxx xxxxx měněn xx doplňován.
Znění jednotlivých xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx v xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx jich xxxxxx xxxxxxxxx změna xxxxx uvedeného xxxxxxxx xxxxxxxx.